|
Press Releases |
|
 |
|
Friday, March 7, 2025 |
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million |
OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its annual results for the year ended December 31, 2024 (the 'Year'), reporting record-high revenue and healthy net profit despite the challenging business landscape. more info >> |
|
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙 |
專營經皮冠狀動脈介入治療(PCI)及經皮腔內血管成形術(PTA)手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司(「業聚醫療」或「集團」;股份代號:6929)今天宣佈截至截至2024年12月31日止年度(「年度」)的全年業績。 more info >> |
|
业聚医疗连续四年实现收入增长 达1.64亿美元创新高 纯利达3,970万美元 建议派发末期股息每股10港仙 |
专营经皮冠状动脉介入治疗(PCI)及经皮腔内血管成形术(PTA)手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司(“业聚医疗”或“集团”;股份代号:6929)今天宣布截至截至2024年12月31日止年度(“年度”)的全年业绩。 more info >> |
|
Friday, August 16, 2024 |
|
OrbusNeich Records Net Profit of US$18.8 Million for the First Half of 2024 |
OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its interim results for the six months ended June 30, 2024 (the 'Reporting Period), with revenue and profit for the period attributable to owners of the Company maintained at US$78.9 million and US$18.8 million respectively despite various market challenges. more info >> |
|
业聚医疗2024年上半年纯利达1,880万美元 |
专营经皮冠状动脉介入治疗(PCI)及经皮腔内血管成形术(PTA)手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司(「业聚医疗」或「集团」;股份代号:6929)今天宣布截至2024年6月30日止六个月(「报告期」)的中期业绩。 more info >> |
|
業聚醫療2024年上半年純利達1,880萬美元 |
專營經皮冠狀動脈介入治療(PCI)及經皮腔內血管成形術(PTA)手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司(「業聚醫療」或「集團」;股份代號:6929)今天宣佈截至2024年6月30日止六個月(「報告期」)的中期業績。 more info >> |
|
Wednesday, April 24, 2024 |
|
业聚医疗合资企业在中国内地启动TricValve临床试验 |
more info >> |
|
業聚醫療合資企業在中國內地啟動TricValve臨床試驗 |
專營經皮冠狀動脈介入治療(PCI)及經皮腔內血管成形術(PTA)手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司(「業聚醫療」或「集團」;股份代號:6929)今天公佈,其合資企業業聚培福有限公司(「業聚培福」)旗下用作治療血流動力學相關的三尖瓣功能不全和腔靜脈回流的產品——TricValve經導管雙腔靜脈瓣膜系統(「TricValve」),已於2024年4月22日在中國內地展開臨床試驗。 more info >> |
|
OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China |
OrbusNeich Medical Group Holdings Limited announced today that the Group's joint venture OrbusNeich P+F Company Limited ("ON P&F") has commenced the clinical trial for the TricValve Transcatheter Bicaval Valve System ("TricValve"), to treat patients with hemodynamically relevant tricuspid insufficiency and caval reflux, on April 22, 2024 across Mainland China. more info >> |
|
Thursday, March 7, 2024 |
|
業聚醫療收入純利雙雙創新高 分別約1.54億美元及4,510萬美元 建議派發末期股息每股10港仙 |
專營經皮冠狀動脈介入治療(PCI)及經皮腔內血管成形術(PTA)手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司(「業聚醫療」或「集團」;股份代號:6929),今天公佈截至2023年12月31日止年度的全年業績。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
HKTDC Research Report: Exploring Opportunities in Hong Kong's Proprietary Chinese Medicine Industry
Jul 24, 2025 17:43 HKT/SGT
|
|
|
ONERHT Foundation's 8th GAIL Forum held on 22 July 2025, Champions Green Leadership Across ASEAN
Jul 24, 2025 14:00 HKT/SGT
|
|
|
Quantum Solutions Announces Strategic Bitcoin Treasury Initiative
Jul 24, 2025 13:51 HKT/SGT
|
|
|
日本東京交易所掛牌企業Quantum Solutions啟動比特幣儲備業務
Jul 24, 2025 13:51 HKT/SGT
|
|
|
日本东京交易所挂牌企业Quantum Solutions启动比特币储备业务
Jul 24, 2025 13:51 HKT/SGT
|
|
|
Fujitsu and Nagoya University develop simulation tech to combat transportation gaps
Jul 24, 2025 12:30 JST
|
|
|
Honda Reveals Details of its Support of the World Athletics Championships Tokyo 25
Jul 24, 2025 12:03 JST
|
|
|
十年佈局成果顯現 百仕達控股擬更名Z Fin Limited確立金融科技核心地位
Jul 24, 2025 10:12 HKT/SGT
|
|
|
十年布局成果显现 百仕达控股拟更名Z Fin Limited确立金融科技核心地位
Jul 24, 2025 10:12 HKT/SGT
|
|
|
中國最大農業互聯網公司一畝田即將登陸納斯達克 整合數百萬農業經紀人
Jul 24, 2025 09:36 HKT/SGT
|
|
|
中国最大农业互联网公司即将登录纳斯达克 整合数百万农业经纪人
Jul 24, 2025 09:20 HKT/SGT
|
|
|
Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration
Jul 24, 2025 09:00 HKT/SGT
|
|
|
아반토코리아, 수원 사무실 광교중앙역 인근으로 이전
Jul 24, 2025 09:00 HKT/SGT
|
|
|
丹麥向通用原子航空系統公司採購四架 MQ-9B「天空衛士」無人機
Jul 23, 2025 22:00 HKT/SGT
|
|
|
丹麦从通用原子航空系统公司采购四架 MQ-9B“天空卫士”无人机
Jul 23, 2025 22:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|